KLTOW — Klotho Neurosciences, Inc.
$0.0860-13.13%
Last close: · regular session
Last 21 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for KLTOW in the TickerWise workspace.
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ
- Employees: 3
- Website: https://klothoneuro.com
Latest SEC filings for KLTOW
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.